Editorial: Targeting metabolism of cancer cells and host to overcome drug resistance: Preclinical and clinical studies

Detalles Bibliográficos
Autores principales: Wang, Lishun, Xu, Hanchen, Wu, Yadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951002/
https://www.ncbi.nlm.nih.gov/pubmed/36845689
http://dx.doi.org/10.3389/fonc.2023.1154661
_version_ 1784893293255983104
author Wang, Lishun
Xu, Hanchen
Wu, Yadi
author_facet Wang, Lishun
Xu, Hanchen
Wu, Yadi
author_sort Wang, Lishun
collection PubMed
description
format Online
Article
Text
id pubmed-9951002
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99510022023-02-25 Editorial: Targeting metabolism of cancer cells and host to overcome drug resistance: Preclinical and clinical studies Wang, Lishun Xu, Hanchen Wu, Yadi Front Oncol Oncology Frontiers Media S.A. 2023-02-10 /pmc/articles/PMC9951002/ /pubmed/36845689 http://dx.doi.org/10.3389/fonc.2023.1154661 Text en Copyright © 2023 Wang, Xu and Wu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Wang, Lishun
Xu, Hanchen
Wu, Yadi
Editorial: Targeting metabolism of cancer cells and host to overcome drug resistance: Preclinical and clinical studies
title Editorial: Targeting metabolism of cancer cells and host to overcome drug resistance: Preclinical and clinical studies
title_full Editorial: Targeting metabolism of cancer cells and host to overcome drug resistance: Preclinical and clinical studies
title_fullStr Editorial: Targeting metabolism of cancer cells and host to overcome drug resistance: Preclinical and clinical studies
title_full_unstemmed Editorial: Targeting metabolism of cancer cells and host to overcome drug resistance: Preclinical and clinical studies
title_short Editorial: Targeting metabolism of cancer cells and host to overcome drug resistance: Preclinical and clinical studies
title_sort editorial: targeting metabolism of cancer cells and host to overcome drug resistance: preclinical and clinical studies
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951002/
https://www.ncbi.nlm.nih.gov/pubmed/36845689
http://dx.doi.org/10.3389/fonc.2023.1154661
work_keys_str_mv AT wanglishun editorialtargetingmetabolismofcancercellsandhosttoovercomedrugresistancepreclinicalandclinicalstudies
AT xuhanchen editorialtargetingmetabolismofcancercellsandhosttoovercomedrugresistancepreclinicalandclinicalstudies
AT wuyadi editorialtargetingmetabolismofcancercellsandhosttoovercomedrugresistancepreclinicalandclinicalstudies

Ejemplares similares